{"filings":[{"id":107168,"accession_number":"0001213900-26-013261","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2026-02-06T23:59:59+00:00","items":["1.01","3.02","2.03","9.01"],"status":"ready","headline":"HealthLynked issues $5.7M secured convertible note to CEO's trust at 12%, convertible at $4.25","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal $5,715,811.98 to Mary S. Dent Gifting Trust (controlled by CEO Dr. Michael Dent).","Note replaces prior debt: $4.34M notes, $737K interest, $340K advances, $301K unpaid compensation.","Matures Feb 2, 2029; 12% interest (18% on default); convertible to common at $4.25/share.","Secured by first-priority lien on all assets; issued under Reg D/4(a)(2) exemption as accredited investor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123503,"accession_number":"0001213900-25-121170","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2025-12-12T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"HealthLynked appoints COO and adds two directors; targets Nasdaq uplist in 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Duncan McGillivray appointed COO effective Dec 8, 2025; base salary $120K/yr, rising to $150K on Nasdaq uplist.","McGillivray receives RSU grant of up to 180K shares: 90K vest ratably over 3 years, 90K upon Nasdaq uplist.","Jason Bishara and Chris G. Pulos appointed to Board effective Dec 1, 2025; each receives $20K annual compensation in shares.","Company plans to uplist to Nasdaq Capital Market in 2026, with McGillivray overseeing capital strategy and investor relations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140180,"accession_number":"0001213900-25-084743","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2025-09-05T23:59:59+00:00","items":["3.03","5.03","7.01","9.01"],"status":"ready","headline":"HealthLynked effects 1-for-100 reverse stock split; shares reduced to ~2.85M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 1-for-100 ratio effective September 4, 2025; CUSIP changed to 42228P 300.","Outstanding shares reduced from 284,778,332 to approximately 2,847,784; authorized shares remain 500M.","Ticker symbol temporarily changed to 'HLYKD' for 20 trading days on OTCQB.","Fractional shares rounded up to whole shares; no fractional shares or cash issued.","Company states split is non-dilutive, intended to boost per-share price for potential institutional investment and uplisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176204,"accession_number":"0001013762-25-002723","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2025-03-26T23:59:59+00:00","items":["1.01","3.02","2.03","9.01"],"status":"ready","headline":"HealthLynked issues $420K convertible note to CEO's trust; extends $1.22M in notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $420,000 convertible promissory note to Mary S. Dent Gifting Trust, controlled by CEO Dr. Michael Dent, to replace undocumented advances from Sep-Nov 2024.","Note matures Sep 20, 2025, bears 12% interest (18% default), convertible into common at $0.0375 per share.","Twelve existing notes totaling $1,216,500 extended to Sep 20, 2025; interest increased from 12% to 15% after March 20, 2025.","Issued 10-year warrant to purchase 1,353,356 shares of common stock at $0.0375 per share as consideration for the extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176203,"accession_number":"0001213900-25-009700","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HealthLynked releases shareholder letter highlighting 2024 product launches and CEO's $3M+ personal investment","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["CEO Michael Dent invested over $3M personally over last 16 months, expressing confidence in company's vision.","Launched ARi, an AI-driven healthcare guide, and filed non-provisional patent for the technology.","Expanded telemedicine services from Florida only to nationwide 24/7 coverage in 2024.","Introduced concierge service and discount prescription drug program through Spark Rx partnership.","Company aims to gradually phase out clinical operations and focus on core HealthLynked network revenue streams."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176202,"accession_number":"0001213900-25-003828","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2025-01-15T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"HealthLynked appoints Jeremy Daniel as part-time CFO; David Rosal resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeremy Daniel appointed CFO effective Jan 15, 2025; replaces David Rosal who resigned without disagreement.","Daniel works two days per week at $66K annual salary; also serves as CFO of Innoveren Scientific since 2019.","Daniel previously CFO at Regenerative Medicine Solutions (2013-19) and controller at Omnicare (2012-14).","Daniel holds MBA from Xavier University, BBA in Accounting from University of Cincinnati, and is a CPA.","CEO Michael Dent cited Daniel's experience in financial operations and strategic planning as key to appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209469,"accession_number":"0001213900-24-081421","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2024-09-24T23:59:59+00:00","items":["1.01","3.02","2.03","9.01"],"status":"ready","headline":"HealthLynked issues $900K convertible notes at 12% with warrant to CEO's trust","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate principal $900,000, net proceeds $855,000 after 5% OID; issued in 10 tranches from July to Sept 2024.","Notes secured by first priority lien on all assets; convertible at $0.0486/share; interest 12% (18% on default).","Warrant to purchase 9,259,258 shares at $0.0486/share for 10 years issued to same purchaser.","Purchaser is Mary S. Dent Gifting Trust, controlled by CEO Dr. Michael Dent; proceeds for working capital.","Notes mature six months from each advance date; unregistered sale under Section 4(a)(2) and Reg D."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227528,"accession_number":"0001213900-24-056163","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2024-06-26T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"HealthLynked appoints William Crupi as COO effective June 25, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William Crupi, 35, previously Operations Manager since April 2023, named COO.","Base salary of $120,000 per year; eligible for employee benefit plans.","Granted 10-year stock option to purchase 300,000 shares at $0.081 per share, vesting ratably over three years.","Crupi has over two decades of healthcare experience including roles at Quigley Eye Specialists and Eye Site of Tampa Bay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227527,"accession_number":"0001213900-24-050045","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["1.01","3.02","2.03","8.01","9.01"],"status":"ready","headline":"HealthLynked CEO Dr. Michael Dent provides $1M convertible note financing via trust","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1M senior secured convertible note to Mary S. Dent Gifting Trust (CEO-controlled) on June 3, 2024.","Note matures June 3, 2025; 12% interest (18% upon default); 5% OID; net proceeds $950,000.","Conversion and warrant exercise price $0.0497; warrant covers 10M shares with 10-year term.","Proceeds used for working capital and general corporate purposes; collateralized by all company assets.","Insider financing underscores CEO commitment to growth and shareholder value, per press release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246367,"accession_number":"0001213900-24-022598","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2024-03-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"HealthLynked appoints David Rosal as CFO effective March 11, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David Rosal, 61, appointed CFO effective immediately on March 11, 2024.","Previously Senior Industry Expert – CFO Analytics at Teradata (June 2008 – Nov 2023).","Prior roles at McDonald's Corp. include Director of Business Integration and Director of Finance.","Base salary of $150,000 per year; eligible for company benefit plans and 2021 Equity Incentive Plan awards.","No family relationships or arrangements with other persons in selection process."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246366,"accession_number":"0001213900-24-002970","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2024-01-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"HealthLynked CFO George O'Leary resigns effective April 4, 2024; stays on board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["George O'Leary resigned as CFO, effective April 4, 2024; not due to any disagreement.","O'Leary will continue to serve as a member of the Board of Directors.","No successor named; Company expressed appreciation for his service as CFO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":263803,"accession_number":"0001213900-23-098864","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2023-12-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HealthLynked issues shareholder letter; details unavailable in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company issued a shareholder letter on December 26, 2023, furnished as Exhibit 99.1.","Letter content not provided in the filing excerpt; no financial or operational specifics disclosed.","Investors should refer to the full letter for material updates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319812,"accession_number":"0001213900-23-021776","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2023-03-21T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"HealthLynked retires $550,000 promissory note with Yorkville in full","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Note issued July 19, 2022, amended Nov 15, 2022; final payment made March 17, 2023.","Retired the note in full with the final scheduled installment; no remaining balance.","Initial principal amount was $550,000; all obligations under the note satisfied."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319811,"accession_number":"0001213900-23-020304","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2023-03-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HealthLynked appoints Paul J. Hobaica, MD to board; Robert Mino resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Independent director Robert Mino resigned March 13, 2023; not due to any disagreement.","Paul J. Hobaica, MD appointed to fill the vacancy, effective March 13, 2023.","Dr. Hobaica is Corporate Medical Director at Arthrex Medical Center.","Compensation: $15,000 in shares through Sep 2023, then at least $20,000 annually.","CEO Dr. Michael Dent says Hobaica's medical leadership will aid platform expansion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319810,"accession_number":"0001213900-23-004434","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2023-01-23T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"HealthLynked sells ACO Health Partners to PBACO for up to $3M cash plus up to $7M in IPO shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["$750K cash at signing; up to $2.25M incremental cash based on physician participation by July 31, 2023.","If PBACO goes public by Aug 2024, HLYK receives shares valued at up to $7M net, half vesting at IPO, half over 5-year earnout.","HealthLynked discontinues ACO/MSO segment; retains right to reacquire AHP at cost until formal transfer by Aug 2024.","PBACO assumes management and operating expenses of AHP effective Jan 17, 2023 under Management Services Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338026,"accession_number":"0001213900-22-073863","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2022-11-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"HealthLynked amends $550K promissory note, extends maturity to March 2023","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Original $550K note matured Jan 19, 2023; maturity extended to March 15, 2023.","Three monthly payments of $112,200 already paid; outstanding principal is $224,400.","Remaining balance payable in four monthly installments of $56,100 starting Dec 15, 2022.","Interest rate 0% (15% upon default) plus 2% annual payment premium.","Note issued to YA II PN, Ltd. (Yorkville) under July 2022 purchase agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338025,"accession_number":"0001213900-22-064963","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2022-10-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HealthLynked CFO O'Leary gets new offer letter with salary $259K, stock grants, options at $0.06","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary $259,000/year effective July 1, 2022; annual bonus 25% of salary tied to financial metrics.","Cash bonus of $50,000 upon uplisting and completion of financing round at that time.","Restricted stock grants: 100,000 shares now, plus 100,000 on each July 1, 2023-2025.","Stock options: 1,200,000 at $0.06 exercise price; 162,500 time-vested, rest performance-based.","Severance: six months base salary if terminated without cause; non-compete period reduced to six months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":355379,"accession_number":"0001213900-22-040974","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2022-07-22T23:59:59+00:00","items":["2.03","9.01"],"status":"ready","headline":"HealthLynked issues $550K promissory note to Yorkville with 5% OID, 5-month maturity","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Note issued July 19, 2022 to YA II PN, Ltd.; net proceeds ~$522,500 after 5% OID.","0% coupon interest; 2% premium on cash repayment; total repayment $561,000 over 5 equal monthly installments.","First installment due Aug 19, 2022 ($112,200); final maturity Jan 19, 2023.","Note may be repaid with proceeds from existing Yorkville equity purchase agreement or in cash."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":355378,"accession_number":"0001213900-22-038237","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2022-07-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"HealthLynked enters equity line for up to 30M shares; issues 895K commitment shares to Yorkville","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Standby Equity Purchase Agreement with YA II PN allows sale of up to 30M shares at 96% of Market Price.","Issued 895,255 commitment shares upfront; paid $10,000 structuring fee.","Note Purchase Agreement provides up to $550,000 promissory note at 0% interest (5% OID), repayable in 5 monthly installments.","Proceeds to be used for working capital and general corporate purposes.","Company to file registration statement covering shares issuable to Yorkville."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373532,"accession_number":"0001213900-22-028266","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2022-05-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HealthLynked acquires Aesthetic Enhancements for $425K; Q1 revenue $1.6M, net loss down 85%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Acquired Aesthetic Enhancements LLC for $425K ($325K cash + $100K stock) adding 4,750 patients and $500K revenue in 2021.","Q1 2022 revenue $1.6M vs $1.8M YoY; net loss improved to ($1.2M) vs ($7.8M) YoY, down 85%.","NASDAQ uplisting postponed until market cap appropriate; shares declared 'Penny Stock Exempt' on OTCQB.","Dr. Kathleen Marc to join Naples Women's Center as gynecologist."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":429366,"accession_number":"0001213900-21-045668","cik":1680139,"company_name":"HealthLynked Corp","ticker":"HLYK","form_type":"8-K","filed_at":"2021-08-30T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"HealthLynked raises $2M in registered direct offering at $0.54/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["3,703,704 shares sold at $0.54 each for gross proceeds of $2M; expected close Aug 31, 2021.","Warrants to purchase 1,851,852 shares at $0.65 per share, exercisable for 5 years from issuance.","Net proceeds of approx. $1.7M to be used for general working capital.","H.C. Wainwright serves as exclusive placement agent; earns 8% cash fee plus compensation warrants.","Shares offered under effective S-3 shelf; warrants issued in unregistered private placement under Section 4(a)(2)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6516439.6323981825,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}